BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Annexon to Present at 41st Annual J.P. Morgan Healthcare Conference

  Annexon, Inc. today announced that Douglas Love, president and chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 7:30 a.m. PT in San Francisco.

  January 4, 2023

   · 

  1 min read
• Genetown

  Nuvalent to Present at the 41st Annual J.P. Morgan Healthcare Conference

  Nuvalent, Inc. today announced that James Porter, Ph.D., Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023.

  January 4, 2023

   · 

  1 min read
• Policy

  Sedana Medical receives FDA Fast Track Designation in the United States

  Sedana Medical AB announces that the U.S. Food and Drug Administration has granted Fast Track Designation for the evaluation of isoflurane via the Sedaconda ACD-S device for sedation of mechanically ventilated patients in the intensive care setting.

  January 4, 2023

   · 

  4 min read
• Pharm Country

  Arvinas to Present at 41st Annual J.P. Morgan Healthcare Conference

  Arvinas, Inc. today announced that John Houston, Ph.D., President and Chief Executive Officer of Arvinas, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 1:30 p.m. PT in San Francisco, Calif.

  January 4, 2023

   · 

  1 min read
• Biotech Bay

  Alladapt to Present at the 41st Annual J.P. Morgan Healthcare Conference

  Alladapt Immunotherapeutics Inc. today announced that Ashley Dombkowski, Chief Executive Officer of Alladapt, will present a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 7:30 a.m. PT in San Francisco, CA.

  January 4, 2023

   · 

  1 min read
• Bio NC

  BioCryst to Present at 41st Annual J.P. Morgan Healthcare Conference

  BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 10, 2023, at 6:00 p.m. ET.

  January 4, 2023

   · 

  1 min read
• Drug Development

  Aravive Announces Complete Enrollment in the Global Registrational Phase 3 AXLerate-OC Trial for Platinum-Resistant Ovarian Cancer

  Aravive, Inc. today announced the achievement of full enrollment in the registrational Phase 3 trial of batiraxcept plus paclitaxel for platinum-resistant ovarian cancer (PROC).

  January 4, 2023

   · 

  6 min read
• Business

  Tonix Pharmaceuticals Appoints Zeil Rosenberg, M.D., M.P.H., as Executive Vice President, Medical for Infectious Disease Programs

  Tonix Pharmaceuticals Holding Corp. today announced the appointment of Zeil Rosenberg, M.D., M.P.H. as its new Executive Vice President, Medical.

  January 4, 2023

   · 

  7 min read
• Business

  Fulcrum Therapeutics Announces CEO Transition - Jan 04, 2023

  Fulcrum Therapeutics, Inc.® announced that Robert J. Gould, Ph.D., former founding chief executive officer of Fulcrum and a current member of the Board of Directors, has been appointed interim chief executive officer, effective January 3, 2023.

  January 4, 2023

   · 

  4 min read
• Biotech Bay

  Coherus BioSciences Management to Present at the 41st Annual J.P. Morgan Healthcare Conference

  Coherus BioSciences, Inc., announced that senior management will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 8:15 a.m. Pacific Time.

  January 4, 2023

   · 

  1 min read